Gizem Karaca Cikrikci

Gizem Karaca Cikrikci

Auto-generated profile, based on publicly available information

Gizem Karaca Cikrikci

Manisa Celal Bayar University, Department of Otolaryngology-Head and Neck Surgery, Manisa, Turkey

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 June 2018 in Brazilian Journal of Otorhinolaryngology
Verified
Journal Article
Open access
GEGorkem Eskiizmir
Gorkem Eskiizmir
UUUzdan Uz
Uzdan Uz
EOEce Onur
Ece Onur
BOBeyhan Ozyurt
Beyhan Ozyurt
GCGizem Karaca Cikrikci
Gizem Karaca Cikrikci
OCOnur Celik
Onur Celik
Systemic inflammatory biomarkers are promising predictive and prognostic factors for solid cancers. The neutrophil-lymphocyte ratio and derived neutrophil-lymphocyte ratio are used to predict inflammation and used as biomarker in several malignancies. The purpose of this study was to demonstrate the diagnostic, predictive and prognostic role of neutrophil-lymphocyte ratio and derived neutrophil-lymphocyte ratio in patients with laryngeal neoplasms. A retrospective study was conducted on medical records involving 229 patients with benign, premalignant and malignant laryngeal neoplasms between 2002 and 2015. The diagnostic, predictive and prognostic role of neutrophil-lymphocyte ratio and derived neutrophil-lymphocyte ratio were evaluated using uni- and multivariate analysis. The neutrophil-lymphocyte ratio and derived neutrophil-lymphocyte ratio were not statistically different between patients with benign, premalignant and malignant laryngeal neoplasms. Both neutrophil-lymphocyte ratio and derived neutrophil-lymphocyte ratio were predictive factors for stage, lymph node metastasis, and distant metastasis. Patients with high neutrophil-lymphocyte ratio value (≥4) had a poor prognosis when compared with patients with low neutrophil-lymphocyte ratio value (5 year, Overall Survival: 69.0% vs. 31.1%, p<0.001; 5 year, disease free survival: 70.0% vs. 32.7%, p˂0.001; 5 year, locoregional recurrence free survival: 69.7% vs. 32.0%, p<0.001). Furthermore, neutrophil-lymphocyte ratio was an independent prognostic factor for 5 year: Overall survival (HR=2.396; 95% CI 1.408-4.077; p=0.001), Disease free survival (HR=2.246; 95% CI 1.322-3.816; p=0.006) and locoregional recurrence free survival (HR=2.210; 95% CI 1.301-3.753; p=0.003). Pretreatment neutrophil-lymphocyte ratio is a useful and reliable predictive and prognostic biomarker for patients with laryngeal carcinoma.

1 September 2019 in Brazilian Journal of Otorhinolaryngology (Versão em Português)
Verified
Journal Article
Closed access
GEGorkem Eskiizmir
Gorkem Eskiizmir
UUUzdan Uz
Uzdan Uz
EOEce Onur
Ece Onur
BOBeyhan Ozyurt
Beyhan Ozyurt
GCGizem Karaca Cikrikci
Gizem Karaca Cikrikci
OCOnur Celik
Onur Celik